4.7 Article

Inhibiting STAT3 signaling pathway by natural products for cancer prevention and therapy: In vitro and in vivo activity and mechanisms of action

Related references

Note: Only part of the references are listed.
Review Oncology

Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature

Chakrabhavi Dhananjaya Mohan et al.

Summary: Signal transducer and activator of transcription 3 (STAT3) is a crucial transcription factor involved in various human malignancies. Its activation promotes tumor progression, while inhibiting STAT3 signaling can effectively suppress tumor growth. This review provides a comprehensive overview of the mechanisms of STAT3 signal transduction, its negative regulators, the role of STAT3 in oncogenesis, and the inhibition of STAT3 signaling by natural compounds with potential anti-tumor activity.

SEMINARS IN CANCER BIOLOGY (2022)

Article Chemistry, Multidisciplinary

10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation

Qun Zhao et al.

Summary: The study identified 10,11-dehydrocurvularin (DCV) as a selective inhibitor of STAT3 for intervention in breast cancer, demonstrating its ability to inhibit proliferation, migration, invasion, and induce apoptosis in breast cancer cell lines. DCV directly engages with STAT3 and inhibits its phosphorylation activity, leading to tumor growth inhibition without observed toxicity in mouse xenograft models.

ACTA PHARMACOLOGICA SINICA (2021)

Article Cell Biology

Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway

Lehe Yang et al.

Summary: Gracillin demonstrates significant anti-tumor activity in human CRC cells by reducing cell viability and migration while stimulating apoptosis. By inhibiting the STAT3 pathway, Gracillin shows potential as an effective treatment for CRC.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Chemistry, Medicinal

Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors

Christine Brotherton-Pleiss et al.

Summary: The study optimized proline-based STAT3 inhibitors into a new series of azetidine-2-carboxamide analogues with sub-micromolar potencies, demonstrating potential therapeutic effects on breast cancer cells.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Plant Sciences

My 60-Year Love Affair with Natural Products

David G. Kingston

Summary: The author discusses his 60-year career in studying the chemistry of natural products, including structural, synthetic, and biosynthetic studies of various natural products like insect pigments, antibiotics, fecal mutagens, taxol, anticancer drugs, and antimalarial drugs. One compound, napabucasin, is highlighted as now being in phase III clinical trials as an anticancer drug.

JOURNAL OF NATURAL PRODUCTS (2021)

Article Pharmacology & Pharmacy

The natural product trienomycin A is a STAT3 pathway inhibitor that exhibits potent in vitro and in vivo efficacy against pancreatic cancer

Qiu-Rui He et al.

Summary: Trienomycin A, a natural product, inhibits the growth, migration, and invasion of pancreatic cancer cells without significant toxicity in mice. This novel therapeutic approach may serve as a potential candidate for the treatment of pancreatic cancer.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors

Sukhvir Kaur et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2020)

Article Chemistry, Multidisciplinary

Quinazoline Ligands Induce Cancer Cell Death through Selective STAT3 Inhibition and G-Quadruplex Stabilization

Jan Jamroskovic et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Article Medicine, Research & Experimental

The JAK2/STAT3 pathway is involved in the anti-melanoma effects of brevilin A

Tao Su et al.

LIFE SCIENCES (2020)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy

Kai-Rui Feng et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Pharmacology & Pharmacy

Anti-metastatic Effects of Baicalein by Targeting STAT3 Activity in Breast Cancer Cells

Gorrepotu Dani Susmitha et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2020)

Article Chemistry, Organic

Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic-inorganic inhibitors

Matthew B. Minus et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2020)

Article Plant Sciences

Diarylheptanoids from Curcuma phaeocaulis Suppress IL-6-Induced STAT3 Activation

Hyun-Jae Jang et al.

PLANTA MEDICA (2019)

Article Oncology

STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer

Ayman J. Oweida et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Review Oncology

STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review

Jiang-Jiang Qin et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Cell Biology

Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway

Weiguo Wang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Review Oncology

STAT3, a Master Regulator of Anti-Tumor Immune Response

Cedric Rebe et al.

CANCERS (2019)

Article Oncology

Reprograming of Glucose Metabolism by Zerumbone Suppresses Hepatocarcinogenesis

Nissar Ahmad Wani et al.

MOLECULAR CANCER RESEARCH (2018)

Article Chemistry, Medicinal

Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors

Jianpeng Guo et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Cucurbitacin I induces pro-death autophagy in A549 cells via the ERK-mTOR-STAT3 signaling pathway

Yinyun Ni et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

Article Plant Sciences

Crispenes F and G, cis-Clerodane Furanoditerpenoids from Tinospora crispa, Inhibit STAT3 Dimerization

Md. Abdullah Al Noman et al.

JOURNAL OF NATURAL PRODUCTS (2018)

Review Oncology

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Daniel E. Johnson et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Review Pharmacology & Pharmacy

Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy

Chitra Rajagopal et al.

PHARMACOLOGICAL RESEARCH (2018)

Article Oncology

Osthole inhibits triple negative breast cancer cells by suppressing STAT3

Xuanxuan Dai et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Article Cell Biology

2-O-Methylmagnolol Induces Apoptosis and Inhibits IL-6/STAT3 Signaling in Oral Squamous Cell Carcinoma

Tong-Hong Wang et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

Article Chemistry, Medicinal

Antagonizing STAT3 activation with benzo[b]thiophene 1, 1-dioxide based small molecules

Wenda Zhang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Crocin Suppresses Constitutively Active STAT3 Through Induction of Protein Tyrosine Phosphatase SHP-1

Buyun Kim et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2017)

Article Multidisciplinary Sciences

Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells

Davide Genini et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Oncology

Targeting STAT3 with silibinin to improve cancer therapeutics

Joaquim Bosch-Barrera et al.

CANCER TREATMENT REVIEWS (2017)

Article Integrative & Complementary Medicine

Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway

Xin Rui et al.

BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)

Review Immunology

Mechanisms and consequences of Jak-STAT signaling in the immune system

Alejandro V. Villarino et al.

NATURE IMMUNOLOGY (2017)

Article Medicine, Research & Experimental

Erianin inhibits indoleamine 2, 3-dioxygenase - induced tumor angiogenesis

Chang Su et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Review Biochemistry & Molecular Biology

Strategies and Approaches of Targeting STAT3 for Cancer Treatment

Stefanie L. Furtek et al.

ACS CHEMICAL BIOLOGY (2016)

Article Biochemistry & Molecular Biology

4-Carbonyl-2,6-dibenzylidenecyclohexanone derivatives as small molecule inhibitors of STAT3 signaling pathway

Peng Ji et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Screening and biological evaluation of a novel STAT3 signaling pathway inhibitor against cancer

Min Huang et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Article Chemistry, Organic

Crispene E, a cis-clerodane diterpene inhibits STAT3 dimerization in breast cancer cells

Julia Mantaj et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2015)

Article Oncology

Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation

Kriengsak Lirdprapamongkol et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2013)

Article Biochemistry & Molecular Biology

Germacrone induces apoptosis in human hepatoma HepG2 cells through inhibition of the JAK2/STAT3 signalling pathway

Yun-yi Liu et al.

JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2013)

Article Oncology

Ellagic Acid and Embelin Affect Key Cellular Components of Pancreatic Adenocarcinoma, Cancer, and Stellate Cells

Mouad Edderkaoui et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2013)

Article Oncology

Mechanism of the inhibition of the STAT3 signaling pathway by EGCG

Yang Wang et al.

ONCOLOGY REPORTS (2013)

Review Pharmacology & Pharmacy

Terpenoids: natural products for cancer therapy

Min Huang et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)

Article Plant Sciences

Small-molecule STAT3 Signaling Pathway Modulators from Polygonum cuspidatum

Jiawei Liu et al.

PLANTA MEDICA (2012)

Article Multidisciplinary Sciences

Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts

Xiaolei Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Biochemistry & Molecular Biology

Cosmomycin C inhibits signal transducer and activator of transcription 3 (STAT3) pathways in MDA-MB-468 breast cancer cell

Jihoon Kim et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2011)

Article Multidisciplinary Sciences

Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity

Khandaker Siddiquee et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Review Oncology

Small molecule inhibitors of Stat3 signaling pathway

Jinxia Deng et al.

CURRENT CANCER DRUG TARGETS (2007)

Article Biochemistry & Molecular Biology

Stattic: A small-molecule inhibitor of STAT3 activation and dimerization

Jochen Schust et al.

CHEMISTRY & BIOLOGY (2006)

Article Biochemistry & Molecular Biology

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

M Kortylewski et al.

NATURE MEDICINE (2005)

Article Biochemistry & Molecular Biology

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

TH Wang et al.

NATURE MEDICINE (2004)